Jonathan Cappel, MD
Procedural Dermatology · Vestavia Hls, ALNPI 1174819049
Payments from drug & device makers
Across 87 payments — averaging $40.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$731
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$476
- Sanofi$282
- E.r. Squibb & Sons, L.L.C.$197
- Regeneron Healthcare Solutions, Inc.$188
- Novartis$172
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,523100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 14 | $731 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $476 |
| Sanofi | 5 | $282 |
| E.r. Squibb & Sons, L.L.C. | 5 | $197 |
| Regeneron Healthcare Solutions, Inc. | 5 | $188 |
| Novartis | 7 | $172 |
| Johnson & Johnson | 4 | $148 |
| Kerecis Limited | 1 | $126 |
| Verrica Pharmaceuticals Inc. | 1 | $125 |
| Sun Pharmaceutical Industries Inc. | 5 | $121 |
| Journey Medical Corporation | 1 | $115 |
| Almirall LLC | 1 | $105 |
| Aclaris Therapeutics, Inc. | 1 | $98 |
| Organogenesis Inc. | 3 | $98 |
| Boehringer Ingelheim | 5 | $92 |
| Lilly USA, LLC | 5 | $81 |
| LEO Pharma Inc. | 3 | $68 |
| Smith+Nephew | 2 | $47 |
| Biofrontera Inc. | 1 | $39 |
| Amgen | 2 | $37 |
| Arcutis Biotherapeutics, Inc. | 2 | $37 |
| Pfizer | 2 | $31 |
| Mayne Pharma Commercial LLC | 1 | $31 |
| Genentech USA, Inc. | 2 | $27 |
| Kyowa Kirin, Inc. | 1 | $20 |
| Bioventus LLC | 1 | $19 |
| Galderma Laboratories, L.p. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Marigen$503
- DUOBRII$328
- Kerecis Omega3 SurgiClose$126
- ALTRENO$125
- YCANTH$125
- LIBTAYO$121
- Tremfya$121
- DUPIXENT$117
- Sotyktu$108
- Seysara$105
How this compares
Too few procedural dermatology providers in Alabamato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 1,612 | $11,020 |
| Fluorouracil | 25 | $2,355 |
| Cephalexin | 69 | $331 |
| Ketoconazole | 22 | $316 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 60 | $164 |
| Triamcinolone Acetonide | 16 | $159 |
| Mupirocin | 14 | $122 |
| Azithromycin | 17 | $96 |
| Tramadol Hcl | 18 | $32 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Vestavia Hls
- Adam SperdutoVestavia Hls$3K
- Retna BillanoVestavia$14K
- Janet CashBirmingham$8K
- Sarah SawyerBirmingham$8K
- Angelo MancusoMadison$544
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.